BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 222840)

  • 1. Limited trypsin cleavage distinguishes MHC and thymus-leukemia antigens.
    Pischel KD; Little JR
    J Immunol; 1979 Aug; 123(2):551-6. PubMed ID: 222840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared chemical properties of different murine thymus-leukemia antigens.
    Pischel KD; Little JR
    J Immunol; 1979 May; 122(5):1821-7. PubMed ID: 448110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface antigens containing beta2-microglobulin as the common subunit.
    Peterson A; Kvist S; Klint M; Wiman K
    Pathol Biol (Paris); 1978 Sep; 26(6):283-9. PubMed ID: 83566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell membrane antigen isolation with the staphylococcal protein A-antibody adsorbent.
    Kessler SW
    J Immunol; 1976 Nov; 117(5 Pt 1):1482-90. PubMed ID: 187693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
    Quackenbush EJ; Letarte M
    J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical analysis of an MHC-linked hematopoietic cell surface antigen, Qa-2.
    Soloski MJ; Vitetta ES; Flaherty L; Uhr JW
    J Supramol Struct Cell Biochem; 1981; 16(2):167-77. PubMed ID: 7299842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of a unique antigen on radiation leukemia virus-induced leukemia B6RV2.
    Nakayama E; Uenaka A; Stockert E; Obata Y
    Cancer Res; 1984 Nov; 44(11):5138-44. PubMed ID: 6091870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thymic differentiation markers T6 and M241 are two unusual MHC class I antigens.
    van de Rijn M; Lerch PG; Knowles RW; Terhorst C
    J Immunol; 1983 Aug; 131(2):851-5. PubMed ID: 6190941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sharing of Ia antigens between species. IV. Interspecies cross-reactivity of monoclonal antibodies directed against polymorphic mouse Ia determinants.
    Lunney JK; Osborne BA; Sharrow SO; Devaux C; Pierres M; Sachs DH
    J Immunol; 1983 Jun; 130(6):2786-93. PubMed ID: 6406596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the leukemic cell associated antigen(s) in mice with myeloid leukemia (Graffi), using the immunoperoxidase techniques.
    Yantchev IK
    Neoplasma; 1979; 26(4):397-404. PubMed ID: 230420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
    Stackpole CW; Demsey A
    Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural relation of murine "third locus" (H-2L) major histocompatibility antigens to the products of H-2K and H-2D loci.
    Rose SM; Hansen TH; Cullen SE
    J Immunol; 1980 Nov; 125(5):2044-50. PubMed ID: 7430620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical analysis of a novel H-2 class I-like glycoprotein expressed in five AKR-(Gross virus) derived spontaneous T cell leukemias.
    Labeta MO; Fernandez N; Reyes A; Ferrara P; Marelli O; Le Roy E; Houlihan J; Festenstein H
    J Immunol; 1989 Aug; 143(4):1245-53. PubMed ID: 2473124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
    Negoro S; Seon BK
    Cancer Res; 1981 Jul; 41(7):2973-6. PubMed ID: 6972802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.